Tower Research Capital (TRC)’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-269,319
| Closed | -$7.26M | – | 6656 |
|
|
2022
Q4 | $7.26M | Buy |
269,319
+143,775
| +115% | +$3.78M | 0.3% | 39 |
|
|
2022
Q3 | $2.25M | Buy |
125,544
+119,074
| +1,840% | +$1.9M | 0.04% | 383 |
|
|
2022
Q2 | $81K | Sell |
6,470
-14,252
| -69% | -$157K | ﹤0.01% | 2460 |
|
|
2022
Q1 | $276K | Buy |
20,722
+9,262
| +81% | +$124K | ﹤0.01% | 1514 |
|
|
2021
Q4 | $179K | Buy |
11,460
+1,310
| +13% | +$25K | ﹤0.01% | 1856 |
|
|
2021
Q3 | $228K | Buy |
+10,150
| New | +$223K | 0.01% | 1697 |
|
|
2021
Q2 | – | Sell |
-3,567
| Closed | -$73K | – | 6053 |
|
|
2021
Q1 | $73K | Sell |
3,567
-3,447
| -49% | -$78.5K | ﹤0.01% | 2827 |
|
|
2020
Q4 | $193K | Buy |
+7,014
| New | +$137K | 0.01% | 1738 |
|
|
2020
Q3 | – | Sell |
-18,387
| Closed | -$379K | – | 5215 |
|
|
2020
Q2 | $379K | Buy |
18,387
+11,861
| +182% | +$161K | 0.02% | 1251 |
|
|
2020
Q1 | $49K | Buy |
6,526
+1,453
| +29% | +$16.3K | ﹤0.01% | 1306 |
|
|
2019
Q4 | $79K | Sell |
5,073
-4,668
| -48% | -$47.1K | 0.01% | 1081 |
|
|
2019
Q3 | $51K | Buy |
9,741
+3,083
| +46% | +$22.9K | ﹤0.01% | 1794 |
|
|
2019
Q2 | $60K | Buy |
+6,658
| New | +$99.3K | ﹤0.01% | 1487 |
|
|
2018
Q3 | – | Sell |
-200
| Closed | -$5K | – | 4391 |
|
|
2018
Q2 | $5K | Buy |
+200
| New | +$4.37K | ﹤0.01% | 3089 |
|
|
2018
Q1 | – | Sell |
-4,741
| Closed | -$60K | – | 4022 |
|
|
2017
Q4 | $60K | Sell |
4,741
-10,339
| -69% | -$139K | 0.01% | 1193 |
|
|
2017
Q3 | $233K | Buy |
15,080
+13,761
| +1,043% | +$167K | 0.02% | 659 |
|
|
2017
Q2 | $15K | Buy |
1,319
+999
| +312% | +$12.4K | ﹤0.01% | 1386 |
|
|
2017
Q1 | $4K | Buy |
320
+220
| +220% | +$2.52K | ﹤0.01% | 2377 |
|
|
2016
Q4 | $1K | Buy |
+100
| New | +$1.16K | ﹤0.01% | 3690 |
|
Other funds holding MYOV
Tower Research Capital (TRC)'s MYOV Position: Q1 2023 in Review
Tower Research Capital (TRC) sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 269,319 shares — an estimated $7.26M sold.
Tower Research Capital (TRC) first reported a position in MYOV in Q4 2016 and held it in 19 quarters. The position peaked at $7.26M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Tower Research Capital (TRC) reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 269,319 Myovant Sciences Ltd. shares in Q1 2023, an estimated $7.26M.
- Tower Research Capital (TRC) first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 19 quarters.
- Tower Research Capital (TRC)'s Myovant Sciences Ltd. position peaked at $7.26M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.